No Data
No Data
Hims +6% Monday After FDA Said it Might Halt Hims Weight Loss Drug Sales Friday
TD Cowen Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,050
Leerink Partners Initiates Eli Lilly and Co(LLY.US) With Buy Rating, Announces Target Price $990
Eli Lilly's (NYSE:LLY) Crohn's Disease Drug Outperforms JNJ's Version
Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030
More Patients On Eli Lilly's Mirikizumab Achieved Histologic Response At One Year Compared To Johnson & Johnson's Drug
No Data
No Data